Organoid-Based Prediction of Ivacaftor Response for Rare CFTR
Source Dekkers et al. · University Medical Centre Utrecht and Erasmus MC, Netherlands
Abstract
Demonstrated that organoid forskolin-induced swelling predicts clinical ivacaftor response for rare CFTR mutations lacking clinical trial data. This paradigm enables drug access through compassionate use programs and has been accepted for reimbursement decisions in the Netherlands.
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Dekkers et al.. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol